Xiidra - Ownership and Business Overview

Medical ProductsCompany

Xiidra Ownership

Who owns Xiidra?

Xiidra is owned by Bausch & Lomb. It was acquired on June 30, 2023.

Xiidra Business Overview

Where is Xiidra headquartered?

Xiidra is headquartered in Basel, Switzerland.

What sector is Xiidra in?

Xiidra is a medical products company.

Medical Products M&A Summary in 2023

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2023. The largest medical products acquisition in 2023 was Limacorporate - which was acquired by Enovis for $902M.

Join Mergr to view all 135 acquisitions of medical products companies in 2023, including 19 acquisitions by private equity firms, and 116 by strategics.

Xiidra

Xiidra

Basel,
Switzerland,
www.xiidra.com

XIIDRA (lifitegrast ophthalmic solution) 5% is a prescription eye drop used to treat the signs and symptoms of dry eye disease. Xiidra is based in Basel, Switzerland.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.